Neuroscience Press Release
| Post date | Title | Picture |
|---|---|---|
| 06/22/2020 - 11:22 |
Dana Foundation Launches New Outreach Grants for Brain Awareness Week New York, NY, June 22, 2020 —The Dana Foundation will launch a grants program in October to support Brain Awareness Week outreach activities in the U.S. and Canada. Held around the world in mid-March, the annual campaign attracts hundreds of partners each year who plan and perform these activities with the goal of fostering public enthusiasm and support for brain science. |
 |
| 06/22/2020 - 10:47 |
New AASM COVID-19 Relief Funds assist sleep societies and research award recipients DARIEN, IL — The American Academy of Sleep Medicine and the AASM Foundation are offering relief funding through new programs created in response to the COVID-19 pandemic. Funds are now available from the AASM for state and regional sleep societies and from the AASM Foundation for research award recipients impacted financially by COVID-19. |
 |
| 06/19/2020 - 12:43 |
UFT celebrates Albert Shanker Scholarship Award winners In spite of the challenges presented by COVID-19, the United Federation of Teachers (UFT) has recognized more than 180 students from New York City’s public high schools and presented each with a $5,000 Albert Shanker college scholarship. |
 |
| 06/18/2020 - 18:25 |
Doctoral student Douglas Morrison recognized by UCLA Fielding School of Public Health for academic excellence with Blann Fellowship UCLA Fielding School of Public Health doctoral student Douglas Morrison has been recognized for academic excellence and commitment to public health as a 2020 recipient of the Celia G. and Joseph G. Blann Fellowship. |
 |
| 06/18/2020 - 14:06 |
Research on cancer, fungal infection, vision loss funded by Michigan Drug Discovery Three innovative drug discovery projects targeting cancer, fungal infection and vision loss are moving forward at the University of Michigan with early-stage funding from Michigan Drug Discovery. |
 |
| 06/18/2020 - 11:25 |
Doctoral student recognized by UCLA Fielding School of Public Health for academic excellence with Blann Fellowship UCLA Fielding School of Public Health doctoral student Douglas Morrison has been recognized for academic excellence and commitment to public health as a 2020 recipient of the Celia G. and Joseph G. Blann Fellowship. |
|
| 06/15/2020 - 16:59 |
Insomnia Awareness Night to shed light on impact of sleeplessness DARIEN, IL – June features the shortest nights of the year, but for those living with chronic insomnia, every night is long. That’s why the American Academy of Sleep Medicine (AASM), Society of Behavioral Sleep Medicine (SBSM) and American Alliance for Healthy Sleep (AAHS) are working to raise awareness of the disease with Insomnia Awareness Night on June 22, 2020. |
|
| 06/12/2020 - 12:08 |
Scientists map how human retinal cells relay information to brain Click to share on Facebook (Opens in new window) Click to share on Twitter (Opens in new window) Click to share on Pinterest (Opens in new window) Click to share on LinkedIn (Opens in new window) |
 |
| 06/11/2020 - 03:53 |
2020 Gruber Neuroscience Prize June 11, 2020, New Haven, CT – The 2020 Gruber Neuroscience Prize is being awarded to Friedrich Bonhoeffer, of the Max Planck Institute for Developmental Biology, Corey Goodman, of venBio, and Marc Tessier-Lavigne, of Stanford University, for their groundbreaking work in elucidating the molecular mechanisms that guide developing axons to their targets, a key step in the formation of neural circuits. |
 |
| 06/11/2020 - 02:49 |
FDA Approves New Therapy for Rare Disease Affecting Optic Nerve, Spinal Cord The U.S. Food and Drug Administration today approved Uplizna (inebilizumab-cdon) injection for intravenous use for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients with a particular antibody (patients who are anti-aquaporin-4 or AQP4 antibody positive). NMOSD is a rare autoimmune disease of the central nervous system that mainly affects the optic nerves and spinal cord. Uplizna is only the second approved treatment for the disorder. |
 |
| 06/11/2020 - 02:42 |
AASM congratulates 2020 Trainee Investigator Award recipients The American Academy of Sleep Medicine congratulates the recipient of the 2020 Trainee Investigator Award, Kent Werner, MD, PhD, and the two individuals who received the honorable mention designation. They will be recognized during the AASM annual membership meeting, which will be held as a webcast on Monday, June 15, at 1 p.m. |
|
| 06/11/2020 - 00:44 |
Benjamin F. Cravatt, PhD, to Receive 2020 AACR Award for Outstanding Achievement in Chemistry in Cancer Research PHILADELPHIA — The American Association for Cancer Research (AACR) is honoring Benjamin F. Cravatt, PhD, with the 2020 AACR Award for Outstanding Achievement in Chemistry in Cancer Research. |
 |
| 06/08/2020 - 16:21 |
Researchers Run Philosophy Experiment in a Lab to Test Objectivity of Vision With a novel series of experiments using sophisticated computer graphics and laser-cut ‘coins,’ the Johns Hopkins team, whose lead author is a neuroscientist with a doctorate in philosophy, found that it’s almost impossible for people to separate an object’s true identity from their own perspective on it. |
 |
| 06/08/2020 - 03:57 |
National honours shine a spotlight on UQ scientists A quartet of top scientists is among members of The University of Queensland community to be recognised in the 2020 Queen’s Birthday Honours. |
 |
| 06/05/2020 - 10:44 |
Study suggests Baboon model could aide in Alzheimers disease interventions The scientists observed a steep age-related cognitive decline in baboons about 20-years-old, which is the equivalent of a 60-year-old human. The team of scientists, led by Dr. Marcel Daadi, Associate Professor at Texas Biomed’s SNPRC, published their findings in the May issue of Aging . These studies are a first step in developing the baboon as an appropriate animal model for early stage Alzheimer’s disease. |
 |
| 06/03/2020 - 12:45 |
Near-atomic blueprint reveals inner workings of drug target for cancer, other diseases GRAND RAPIDS, Mich. (June 3, 2020) — Van Andel Institute scientists have for the first time described the near-atomic level structure of a molecular pathway that plays critical roles in human development, blood pressure regulation, inflammation and cell death. The findings were published today in the journal Nature. |
 |
| 06/01/2020 - 10:20 |
Brain circuitry triggers a wanting for what hurts ANN ARBOR—Stimulating the brain’s circuitry related to addiction can create strong desires even for something that hurts. |
|
| 05/28/2020 - 00:51 |
Novartis data highlight benefit of early treatment initiation in patients with secondary progressive multiple sclerosis (SPMS) Novartis presented a total of 34 abstracts at the Congress of the European Academy of Neurology (EAN), emphasizing its strong multiple sclerosis (MS) portfolio with 20 abstracts. |
 |
| 05/27/2020 - 22:53 |
FDA Approves First Drug to Image Tau Pathology in Patients Being Evaluated for Alzheimers Disease Today, the U.S. Food and Drug Administration approved Tauvid (flortaucipir F18) for intravenous injection, the first drug used to help image a distinctive characteristic of Alzheimer’s disease in the brain called tau pathology. Tauvid is a radioactive diagnostic agent for adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease. Tauvid is indicated for positron emission tomography (PET) imaging of the brain to estimate the density and distribution of aggregated tau neurofibrillary tangles (NFTs), a primary marker of Alzheimer’s disease. |
|
| 05/27/2020 - 11:44 |
Geisinger researchers lead critical review of evidence for autism-specific genes DANVILLE, Pa. – Geisinger researchers led a group of international neuroscience and genetics experts to challenge recent claims that there are genes that specifically cause autism. |
 |
| 05/27/2020 - 10:46 |
Yale researchers find where stress lives Yale researchers have found a neural home of the feeling of stress people experience, an insight that may help people deal with the debilitating sense of fear and anxiety that stress can evoke, Yale researchers report May 27 in the journal Nature Communications . |
 |
| 05/27/2020 - 09:55 |
2020 Kavli Prize Laureates in Neuroscience The Kavli Prize in Neuroscience is awarded to David Julius and SfN member Ardem Patapoutian for their independent discoveries of sensory receptors for temperature and pressure, respectively. While the mechanisms for smell and vision have long been described, a specific molecular understanding for how physical properties like temperature and pressure are detected and encoded into electrical signals the brain can process had been lacking. |
|
| 05/27/2020 - 07:36 |
Jazz Pharmaceuticals Announces Participation at Two Upcoming Virtual Investor Conferences DUBLIN , May 27, 2020 / / -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will webcast its corporate presentations at the following virtual investor conferences: |
 |
| 05/26/2020 - 15:26 |
David Geffen School of Medicine at UCLA names 2020 Switzer Prize recipient Amita Sehgal, whose pioneering discoveries of mechanisms that regulate circadian rhythms and sleep have deepened scientists’ understanding of behavioral cycles, metabolism and healthy aging, has been named the 2020 recipient of the Switzer Prize awarded by the David Geffen School of Medicine at UCLA . |
 |
| 05/25/2020 - 08:49 |
Problems with alcohol? 29 gene variants may explain why A genome-wide analysis of more than 435,000 people has identified 29 genetic variants linked to problematic drinking, researchers at Yale University School of Medicine and colleagues report May 25 in the journal Nature Neuroscience. |
|
